Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Research News
back to News Search
News Brief: Neurexin Splicing Exerts Control Across the Synapse

July 11, 2013. A new study published July 3 in Cell finds that alternative splicing of neurexin 3, a presynaptic cell adhesion molecule, can influence synapse function and plasticity on the postsynaptic side. Led by Thomas Südhof of Stanford University, Palo Alto, California, the study is the first to design a knock-in mouse that constitutively expresses a specific splice variant—in this case, one containing the alternatively spliced sequence #4 (SS4)—to probe its role at the synapse. This manipulation decreased signals through the AMPA subtype of glutamate receptor on the postsynaptic side and interfered with long-term potentiation (LTP) there, – something that indicates presynaptic “permission” is necessary for postsynaptic plasticity.

The findings may offer insight into the workings of neurexin 1, whose gene has been implicated in schizophrenia and autism (see SRF related news story). With three neurexin genes in humans, each with five different splice sites, thousands of different neurexin variants are possible, and they don’t all bind to the same postsynaptic molecules, which include neuroligins and leucine-rich repeat transmembrane proteins (LRRTMs) (see SRF related news story). These postsynaptic partners then interact with a variety of other molecules responsible for getting signals from one neuron to the next. SS4-containing neurexins selectively bind to neuroligin 1 (Siddiqui et al., 2010), and this partnership could result in the change in AMPA receptor trafficking and stabilization found in the new study.

Splice variants have been suspected in schizophrenia before, and transcriptome profiling now enables researchers to track their expression comprehensively (see SRF related news story). By finding that a splice variant can reshape synapse function, the new study affirms the importance of these variants and suggests that, for schizophrenia—often touted as a disorder of disconnectivity—the disconnect may lies not so much in the physical contact between two neurons, but in the workings of their synaptic machinery.—Michele Solis.

Reference:
Aoto J, Martinelli DC, Malenka RC, Tabuchi K, Südhof TC. Presynaptic Neurexin-3 Alternative Splicing trans-Synaptically Controls Postsynaptic AMPA Receptor Trafficking. Cell. 2013 Jul 3;154(1):75-88. Abstract

 
Submit a Comment on this News Article
Make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Affiliation  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
 
Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend the Primary Papers

Please note: A member needs to be both registered and logged in to submit a comment.

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


SRF News
SRF Comments
Text Size
Reset Text Size
Share/Bookmark
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright